New heart valve device offers hope for inoperable patients
NCT ID NCT06568003
Summary
This study is testing a new heart valve device called the LuX-Valve Plus System for people with severe tricuspid regurgitation (a leaky heart valve) who are too high-risk for traditional surgery. The device is inserted through a vein without open-heart surgery. Researchers will check if it's safe and reduces the valve leakage in 15 participants who can't have standard surgical treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION (TR) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Montefiore Medical Center
New York, New York, 10467, United States
Conditions
Explore the condition pages connected to this study.